OTC:MCLE
Medicale Corp.
A financially distressed OTC healthcare entity reporting zero revenue and severe liquidity constraints with accumulated net losses.
Key Metrics
Investment Thesis
Bull Case
An investor might consider the stock only for speculative turnaround potential if the company successfully pivots to a profitable business model or acquires assets. The high financing cash flow suggests active management efforts to raise capital for restructuring or new ventures, which could theoretically unlock value. However, any investment would be highly risky given the complete absence of revenue and negative equity position.
Bear Case
The stock should be avoided due to fundamental financial distress evidenced by zero revenue, zero assets, and a massive accumulated deficit in retained earnings. The company has exhausted its cash reserves and operates with liabilities that far exceed its net worth, indicating a high risk of delisting or liquidation. Without a clear path to profitability or significant asset acquisition, the investment carries near-total downside risk with no intrinsic value support.
About Medicale Corp.
Medicale Corp. (MCLE) is a small-cap OTC-listed entity operating within the healthcare sector with no reported revenue or assets in recent filings. The company faces significant liquidity challenges as it carries substantial liabilities relative to its negative equity and zero cash reserves. Key financial metrics indicate a pattern of operational losses driven by high general and administrative expenses without corresponding income generation.
Analysis
Management Discussion
Recent financial performance is characterized by a net loss of $41,153 driven entirely by operating expenses of $33,493 in the absence of any revenue. While financing activities generated $22,849 in cash flow, this was insufficient to cover operational deficits and working capital changes, resulting in a complete depletion of cash reserves. The balance sheet reflects a precarious state with total liabilities of $140,086 against negative shareholders' equity of -$140,086.
Industry Overview
The healthcare industry is typically capital-intensive and highly regulated, requiring substantial assets, consistent revenue streams, and strong cash flows to maintain market position. Companies operating in this sector usually report positive gross profits and diversified product lines, unlike this entity which shows no operational activity. The OTC market hosts many distressed entities, making it difficult to distinguish viable players from those with unsustainable financial structures like MCLE.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Operating Expenses | $37.6K | $54.7K | $33.5K |
| Operating Income | $-37.6K | $-54.7K | $-33.5K |
| G&A | $37.6K | $54.7K | $33.5K |
| Other OpEx | $0 | $0 | $0 |
| Non-Operating Income | $0 | $-3.5K | $0 |
| Pre-Tax Income | $-37.6K | $-58.2K | $-33.5K |
| Income Tax | $0 | $0 | $0 |
| Continuing Ops | $-37.6K | $-58.2K | $-33.5K |
| Discontinued Ops | $455 | $0 | $0 |
| Net Income | $-37.1K | $-58.2K | $-41.2K |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-37.1K | $-58.2K | $-41.2K |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Current Assets | $159 | $159 | $0 |
| Long-Term Assets | $0 | $0 | $0 |
| Total Assets | $159 | $159 | $0 |
| Current Liabilities | $40.9K | $15.5K | $33.7K |
| Long-Term Liabilities | $0 | $83.6K | $106.4K |
| Total Liabilities | $40.9K | $99.1K | $140.1K |
| Shareholders' Equity | $-40.7K | $-98.9K | $-140.1K |
| Paid-In Capital | $76.3K | $76.3K | $76.3K |
| Retained Earnings | $-117.6K | $-175.8K | $-217.0K |
| Total L&E | $159 | $159 | $0 |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Income (CFO) | $-37.1K | $-58.2K | $-41.2K |
| Non-Cash Adjustments | $0 | $0 | $0 |
| Working Capital Changes | $11.4K | $-25.4K | $18.1K |
| Cash from Operations | $-25.7K | $-83.6K | $-23.0K |
| Cash from Investing | $0 | $0 | $0 |
| Cash from Financing | $25.9K | $83.6K | $22.8K |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $159 | $0 | $-159 |
| Beginning Cash | $0 | $159 | $159 |
| Ending Cash | $159 | $159 | $0 |
Frequently Asked Questions
How does Medicale Corp. make money?
The company's financial statements show no identifiable revenue streams or cost of goods sold, suggesting a lack of active commercial operations. All reported operating expenses consist entirely of general and administrative costs, indicating potential fundraising activities or administrative maintenance rather than product sales. The absence of current assets and total assets implies the business may be in a dormant or restructuring phase without traditional segmental income.
What are the main risks for MCLE?
The company faces imminent liquidity risk with ending cash at zero and total liabilities exceeding total equity, creating a high probability of insolvency. Investors are exposed to dilution risk as the firm relies on financing cash flows to sustain operations while burning through negative net income. There is significant regulatory and delisting risk for an OTC stock with no revenue and accumulated deficits that could trigger bankruptcy proceedings.
What is MCLE's competitive advantage?
The company currently holds no verifiable competitive advantages given its zero revenue, negative shareholders' equity, and lack of operating assets. Any perceived market presence is not supported by financial data showing profitable operations or established product lines. The firm's primary 'asset' remains its ability to raise capital through financing cash flows despite a severe deficit in retained earnings.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.